Comparison results
Add for comparison more than one drug or diagnosis.
| Results: Differences General | ✘Histioplasmosis | |||||||||
| Related research | Analogs | |||||||||
| ||||||||||
| Distinctive symptoms | ||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | |||||||||
| Register, to see more distinctive signs of diseases and studies | 56% | |||||||||
| changeable stool | 52% | |||||||||
| sowing for intestinal flora is positive | 49% | |||||||||
| bilateral pneumonia | 49% | |||||||||
| fungal mycosis | 46% | |||||||||
| systemic mycosis | 44% | |||||||||
| papules | 41% | |||||||||
| increased | 40% | |||||||||
| reaction to manta rays | 40% | |||||||||
| sowing on intestinal flora | 40% | |||||||||
| pneumonia in children | 38% | |||||||||
| eosinophilia | 38% | |||||||||
| interstitial pneumonia | 37% | |||||||||
| allergies in children | 37% | |||||||||
| acute allergic reactions | 37% | |||||||||
| hepatosplenomegaly | 35% | |||||||||
| blood diseases | 35% | |||||||||
| allergic rash | 35% | |||||||||
| rash on the body | 35% | |||||||||
| gastric bleeding | 34% | |||||||||
| enlargement of the liver and spleen | 34% | |||||||||
| enlarged lymph nodes | 34% | |||||||||
| bleeding ulcer | 34% | |||||||||
| increased ESR | 34% | |||||||||
| intestinal bleeding | 33% | |||||||||
| calcification | 33% | |||||||||
| enlargement of the spleen | 33% | |||||||||
| diseases of infants | 33% | |||||||||
| sputum | 32% | |||||||||
| lymph node damage | 32% | |||||||||
| enlarged liver | 31% | |||||||||
| respiratory insufficiency | 31% | |||||||||
| smokes | 30% | |||||||||
| bacteremia | 30% | |||||||||
| increased bleeding | 30% | |||||||||
| intestinal insufficiency syndrome | 30% | |||||||||
| pneumonia | 30% | |||||||||
| changes in the blood | 29% | |||||||||
| peptic ulcer | 29% | |||||||||
| sepsis | 29% | |||||||||
| drug allergy | 29% | |||||||||
| calcium | 28% | |||||||||
| impaired gastric function | 28% | |||||||||
| acute condition | 28% | |||||||||
| increased sensitivity | 28% | |||||||||
| necrosis | 27% | |||||||||
| bleeding | 27% | |||||||||
| allergy | 27% | |||||||||
| impaired lung function | 26% | |||||||||
| gastrointestinal problems | 26% | |||||||||
| diseases of the gastrointestinal tract | 26% | |||||||||
| drug disease | 25% | |||||||||
| childhood diseases | 25% | |||||||||
| oncology | 24% | |||||||||
Instructions
Video 
|
